<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-29399" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Early Pregnancy Loss (Spontaneous Abortion)</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Alves</surname>
            <given-names>Clark</given-names>
          </name>
          <aff>Abrazo Family Medicine Residency</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Jenkins</surname>
            <given-names>Suzanne M.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rapp</surname>
            <given-names>Amanda</given-names>
          </name>
          <aff>Abrazo Central Campus</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Clark Alves declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Suzanne Jenkins declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Amanda Rapp declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>12</day>
          <month>10</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-29399.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Early pregnancy loss, characterized by the spontaneous termination of an intrauterine pregnancy during the first trimester, presents a complex clinical scenario requiring multifaceted understanding and management. Detecting and addressing this condition effectively necessitates a&#x000a0;personalized approach due to its various manifestations and stages.&#x000a0;Accurate diagnosis, particularly in the early stages of gestation, can pose a significant challenge, and the lack of a comprehensive understanding of risk factors, differential diagnoses, and a&#x000a0;failure to tailor management strategies to individual patient needs may result in suboptimal care. Counseling skills and enhanced empathy also contribute to better patient care and outcomes, as management needs to be personalized for each patient.</p>
        <p>Healthcare professionals must recognize that early pregnancy loss encompasses multiple subtypes, each associated with distinct risk factors that demand thorough consideration. The healthcare team's ability to provide empathetic counseling is pivotal in delivering superior patient care and achieving favorable outcomes. In this context, fostering enhanced communication skills and empathy plays a vital role in improving patient experiences and outcomes, as management approaches must be precisely tailored to each patient's unique diagnosis and circumstances.&#x000a0;This activity describes the evaluation and management of early pregnancy loss and highlights the role of the interprofessional team in improving patient care.&#x000a0;</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the clinical findings typically found in the various stages of early pregnancy loss.</p></list-item><list-item><p>Identify the essential steps to diagnose early pregnancy loss.</p></list-item><list-item><p>Select the most appropriate management options based on the clinical situation and patient preferences.</p></list-item><list-item><p>Collaborate and communicate with the healthcare team to improve outcomes in patients affected by early pregnancy loss.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29399&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29399">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-29399.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The terminology used to describe the loss of an intrauterine pregnancy before&#x000a0;fetal viability (ie, a fetus likely to survive outside of the uterus) is inconsistent in the literature and has varied over time.<xref ref-type="bibr" rid="article-29399.r1">[1]</xref><xref ref-type="bibr" rid="article-29399.r2">[2]</xref>&#x000a0;Traditionally,&#x000a0;<italic toggle="yes">spontaneous abortion</italic>&#x000a0;referred to a natural pregnancy loss before 20 weeks of gestation; however, more recently, the medical literature has been transitioning away from the phrase.<xref ref-type="bibr" rid="article-29399.r3">[3]</xref>&#x000a0;Patients prefer the term <italic toggle="yes">miscarriage</italic>,&#x000a0;presumably to avoid the stigma associated with induced abortion.<xref ref-type="bibr" rid="article-29399.r1">[1]</xref>&#x000a0;The reVITALize gynecology definitions from the American College of Obstetricians and Gynecologists (ACOG), which are also endorsed by the American Academy of Nurse-Midwives, the American Academy of Family Physicians, and numerous other American professional organizations, now recommend the terms <italic toggle="yes">miscarriage&#x000a0;</italic>or <italic toggle="yes">intrauterine pregnancy loss</italic>. Both terms are synonymous and are defined as the loss of a documented nonviable (ie, a pregnancy not expected to develop normally) intrauterine pregnancy.<xref ref-type="bibr" rid="article-29399.r4">[4]</xref>&#x000a0;</p>
        <p>Some organizations use the cut-off of &#x0003c;10 weeks of gestation to define an <italic toggle="yes">early miscarriage</italic>. The&#x000a0;ACOG and the European Society of Human Reproduction and Embryology (ESHRE) use a similar term&#x02014;early pregnancy loss. ACOG defines it&#x000a0;as "an empty gestational sac or a gestational sac containing an embryo or fetus without fetal heart activity within the first 12 6/7 weeks of gestation," while the ESHRE considers an early loss as occurring before 10 weeks of gestation.<xref ref-type="bibr" rid="article-29399.r5">[5]</xref><xref ref-type="bibr" rid="article-29399.r6">[6]</xref>&#x000a0;Although there is no consensus among societies concerning the correct terminology, early pregnancy loss will be used here, defined in concordance with ACOG as a nonviable intrauterine pregnancy &#x02264;12 6/7 weeks of gestation.<xref ref-type="bibr" rid="article-29399.r5">[5]</xref>&#x000a0;</p>
        <p>
<bold>Classification</bold>
</p>
        <p>Early pregnancy loss is a process and may be diagnosed at multiple stages.</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Biochemical pregnancy</bold>
<bold>loss:</bold> A diagnosis entirely based on decreasing human chorionic gonadotropin levels without a pregnancy ever visualized on ultrasound. Generally, miscarriage occurs before 6 weeks of gestation in pregnancies achieved with the assistance of reproductive technology.<xref ref-type="bibr" rid="article-29399.r7">[7]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Asymptomatic pregnancy loss (ie,&#x000a0;missed abortion):</bold> The missed death of the embryo or fetus without symptoms or expulsion of the products of conception (POC).<xref ref-type="bibr" rid="article-29399.r8">[8]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Threatened pregnancy loss:</bold> Symptoms (eg, bleeding and cramping) of an impending early pregnancy loss; however, the cervical os remains closed, and the embryo or fetus still appears viable on ultrasound.<xref ref-type="bibr" rid="article-29399.r9">[9]</xref><xref ref-type="bibr" rid="article-29399.r10">[10]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Inevitable pregnancy loss:</bold> Similar to a threatened pregnancy loss, symptoms (eg, bleeding and cramping) are present; however, the cervical os is open. This term, in particular, is falling out of favor, as it can be clinically challenging to identify inevitable abortions with certainty.<xref ref-type="bibr" rid="article-29399.r3">[3]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Incomplete pregnancy loss:</bold>&#x000a0;POC that remains within the uterus and the open cervical os after the diagnosis of an early pregnancy loss.<xref ref-type="bibr" rid="article-29399.r11">[11]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Complete pregnancy loss:</bold>&#x000a0;The passage of all POC.<xref ref-type="bibr" rid="article-29399.r3">[3]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Recurrent pregnancy loss:</bold> The consecutive loss of multiple pregnancies. The American Society for Reproductive Medicine defines recurrent as &#x02265;2 pregnancy losses; other organizations define it as &#x02265;3 consecutive losses.<xref ref-type="bibr" rid="article-29399.r12">[12]</xref><xref ref-type="bibr" rid="article-29399.r13">[13]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Septic miscarriage:</bold> An early pregnancy loss complicated by an intrauterine infection, which is rare. Alternatively,&#x000a0;septic abortion has traditionally been used to mean any pregnancy loss, spontaneous or induced, complicated by infection. Septic abortions occur most often in the setting of nonsterile abortion procedures.<xref ref-type="bibr" rid="article-29399.r14">[14]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-29399.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>In more than 60% of pregnancy losses between 6 to 10 weeks of gestation, the etiology is believed to be fetal chromosomal abnormalities, including trisomies, monosomy, and polyploidy.<xref ref-type="bibr" rid="article-29399.r5">[5]</xref><xref ref-type="bibr" rid="article-29399.r15">[15]</xref><xref ref-type="bibr" rid="article-29399.r16">[16]</xref>&#x000a0;Additionally, inflammatory and immunologic dysregulation is thought to play a role in some cases, likely due to the effect on trophoblastic invasion.<xref ref-type="bibr" rid="article-29399.r17">[17]</xref><xref ref-type="bibr" rid="article-29399.r18">[18]</xref><xref ref-type="bibr" rid="article-29399.r19">[19]</xref></p>
        <p>
<bold>Risk Factors</bold>
</p>
        <p>The most common risk factor for early pregnancy loss is advanced maternal age.<xref ref-type="bibr" rid="article-29399.r5">[5]</xref> For example, the incidence of early pregnancy loss in women aged 20 to 30 years is only 9% to 17%, while the incidence at 45 years of maternal age is 75% to 80%.<xref ref-type="bibr" rid="article-29399.r5">[5]</xref>&#x000a0;A prior history of pregnancy loss also increases the risk of recurrent pregnancy loss, with the risk increasing after each additional loss. For example, the risk of miscarriage in a future pregnancy is approximately 20% after one miscarriage, 28% after 2 consecutive miscarriages, and 43% after &#x02265;3 consecutive miscarriages.<xref ref-type="bibr" rid="article-29399.r20">[20]</xref>&#x000a0;Additionally, first-trimester vaginal bleeding, which occurs in up to 25% of pregnancies, is associated with a higher risk of pregnancy loss.<xref ref-type="bibr" rid="article-29399.r21">[21]</xref><xref ref-type="bibr" rid="article-29399.r3">[3]</xref></p>
        <p>Several chronic diseases can predispose a pregnant patient to early pregnancy loss,&#x000a0;including obesity, diabetes, hyperprolactinemia, celiac disease, thyroid disease, and autoimmune conditions, particularly antiphospholipid syndrome.<xref ref-type="bibr" rid="article-29399.r22">[22]</xref><xref ref-type="bibr" rid="article-29399.r23">[23]</xref><xref ref-type="bibr" rid="article-29399.r24">[24]</xref>&#x000a0;Furthermore,&#x000a0;some infections are associated with an increased risk of early pregnancy loss, such as syphilis, parvovirus B19, Zika virus, and cytomegalovirus infections.<xref ref-type="bibr" rid="article-29399.r25">[25]</xref>&#x000a0;Structural uterine abnormalities (eg, congenital M&#x000fc;llerian anomalies, leiomyoma, and intrauterine adhesions) and intrauterine pregnancies with an intrauterine device still in place also have been shown to increase the risk of early pregnancy loss.<xref ref-type="bibr" rid="article-29399.r16">[16]</xref>&#x000a0;Chronic stress secondary to social determinants of health (eg, racism, housing or food insecurity, or living under threats of violence) is also associated with an increased risk of pregnancy loss.<xref ref-type="bibr" rid="article-29399.r17">[17]</xref> Additional modifiable risk factors include alcohol consumption, smoking, cocaine use, and high caffeine consumption (eg, drinking &#x0003e;3 cups of coffee daily).<xref ref-type="bibr" rid="article-29399.r22">[22]</xref> Finally, environmental contaminants, including arsenic, lead, and organic solvents, have also been associated with early pregnancy loss.&#x000a0;</p>
      </sec>
      <sec id="article-29399.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Overall, 10% to 20% of clinically recognized pregnancies will end in early pregnancy loss.<xref ref-type="bibr" rid="article-29399.r5">[5]</xref><xref ref-type="bibr" rid="article-29399.r26">[26]</xref>&#x000a0;However, these statistics likely underestimate the true incidence of spontaneous loss, as many miscarriages remain undiagnosed, with the resulting bleeding being mistaken as heavy, late menses. Studies that have tracked pregnancies using daily measurements of serum &#x003b2;-hCG levels estimate a higher incidence of approximately 38%.<xref ref-type="bibr" rid="article-29399.r16">[16]</xref>&#x000a0;Additionally, 12% to 57% of pregnancies with first-trimester bleeding end in miscarriage.<xref ref-type="bibr" rid="article-29399.r27">[27]</xref></p>
      </sec>
      <sec id="article-29399.s5" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>
<bold>General Principles</bold>
</p>
        <p>The approach to evaluating a pregnant patient with first-trimester bleeding for possible pregnancy loss depends on knowing the location and viability of the pregnancy. Therefore, assessment of a pregnant patient with suspected or threatened early pregnancy loss primarily involves:</p>
        <list list-type="bullet">
          <list-item>
            <p>Determination of the stability of the patient</p>
          </list-item>
          <list-item>
            <p>Exclusion of differential diagnoses (eg, ectopic or molar pregnancies)&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Confirmation of the viability of the pregnancy or, if nonviable, the stage of pregnancy loss&#x000a0;<xref ref-type="bibr" rid="article-29399.r5">[5]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Clinical Features</bold>
</p>
        <p>Symptoms of&#x000a0;early pregnancy loss depend on the type or stage of loss. An asymptomatic pregnancy loss (ie, missed abortion) may only be notable due to the regression of common pregnancy signs and symptoms (eg, nausea or fatigue).<xref ref-type="bibr" rid="article-29399.r21">[21]</xref><xref ref-type="bibr" rid="article-29399.r8">[8]</xref>&#x000a0;Patients with threatened, incomplete, or complete pregnancy losses commonly report pelvic cramping and vaginal bleeding symptoms. A thorough history of the patient's vaginal bleeding (eg, the first day of the last menstrual period, the onset of abnormal uterine bleeding, the number of soaked pads in an hour, and the number and size of clots, if present) should be documented.<xref ref-type="bibr" rid="article-29399.r3">[3]</xref> In addition to these symptoms, septic miscarriages are typically also accompanied by uterine tenderness, purulent cervical and vaginal discharge, and in severe cases, systemic signs (eg, fever, tachycardia, and hypotension).<xref ref-type="bibr" rid="article-29399.r14">[14]</xref>&#x000a0;</p>
        <p>
<bold>Physical Examination</bold>
</p>
        <p>In addition to assessing for signs of pregnancy loss, a focused physical examination, including vital signs and a thorough abdominal and pelvic examination, will assist in determining if&#x000a0;hemodynamic instability and/or possible ectopic pregnancy need to be emergently addressed. Findings from an&#x000a0;abdominal exam may include peritoneal signs of an ectopic pregnancy or extra-uterine extension of a septic abortion.<xref ref-type="bibr" rid="article-29399.r3">[3]</xref>&#x000a0;A pelvic exam, which&#x000a0;should include speculum-facilitated visualization of the cervix and bimanual palpation, is central to evaluating suspected miscarriage.<xref ref-type="bibr" rid="article-29399.r3">[3]</xref>&#x000a0;Findings of early pregnancy loss on pelvic examination may include an open or closed cervix, the presence or absence of pregnancy tissue within the cervical os, vaginal bleeding, and signs suggestive of a septic abortion (eg, purulent discharge, uterine or cervical motion tenderness).<xref ref-type="bibr" rid="article-29399.r3">[3]</xref><xref ref-type="bibr" rid="article-29399.r27">[27]</xref> Alternatively, an adnexal mass finding suggests an ectopic pregnancy rather than an early pregnancy loss. An estimation of the volume of vaginal bleeding should be obtained during the pelvic examination as part of the assessment for hemodynamic stability by noting how quickly blood fills the vaginal vault, which can be significant even in the absence of sepsis. Bleeding similar to or greater than typical menses suggests a diagnosis of early pregnancy loss.<xref ref-type="bibr" rid="article-29399.r3">[3]</xref><xref ref-type="bibr" rid="article-29399.r27">[27]</xref></p>
      </sec>
      <sec id="article-29399.s6" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>
<bold>Diagnostic Studies</bold>
</p>
        <p>Verifying the location of a pregnancy within the uterus and assessing viability are the next steps in evaluating early pregnancy loss. Accurate diagnosis of early pregnancy loss is essential before initiating any treatment to prevent unintended consequences, including termination of a normally developing early pregnancy or engineering birth defects.<xref ref-type="bibr" rid="article-29399.r5">[5]</xref> Differentiating viable from nonviable pregnancies, in addition to excluding differential diagnoses (eg, pregnancy complications or pelvic infection), typically begins with the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Pelvic ultrasound</p>
          </list-item>
          <list-item>
            <p>Quantitative serum &#x003b2;-hCG level&#x000a0;<xref ref-type="bibr" rid="article-29399.r5">[5]</xref></p>
          </list-item>
        </list>
        <p>The first day of the last menstrual period (LMP) and findings from any prior ultrasound imaging performed during the current pregnancy should be reviewed. The LMP is used to initially calculate the estimated gestational age of the pregnancy, and ultrasound imaging, when available, can be used to confirm this dating and determine the location of the pregnancy (eg, intrauterine or ectopic).<xref ref-type="bibr" rid="article-29399.r3">[3]</xref>&#x000a0;Trending &#x003b2;-hCG levels with the findings from pelvic ultrasound assist in assessing the viability of the pregnancy.<xref ref-type="bibr" rid="article-29399.r3">[3]</xref></p>
        <p>
<bold>Additional Studies</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Hemoglobin and hematocrit: to assess acute blood loss anemia; large volumes of acute blood loss may not be accurately reflected in lab values&#x000a0;<xref ref-type="bibr" rid="article-29399.r5">[5]</xref><xref ref-type="bibr" rid="article-29399.r3">[3]</xref></p>
          </list-item>
          <list-item>
            <p>Maternal ABO blood type and Rh status: to prepare for possible blood transfusion or determine the need for anti-Rh immunoglobulin&#x000a0;<xref ref-type="bibr" rid="article-29399.r5">[5]</xref><xref ref-type="bibr" rid="article-29399.r3">[3]</xref></p>
          </list-item>
          <list-item>
            <p>Wet mount examination; bacterial and viral cultures (eg, of cervical, urine, blood, and evacuated gestational tissue): to evaluate suspected septic abortion&#x000a0;<xref ref-type="bibr" rid="article-29399.r28">[28]</xref><xref ref-type="bibr" rid="article-29399.r14">[14]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Early Intrauterine Pregnancies</bold>
</p>
        <p>Pregnancy location can be definitively established once embryonic or fetal structures (eg, a yolk sac or fetal pole) are visible within an intrauterine gestational sac. For individuals with previously diagnosed intrauterine pregnancies, the diagnosis of early pregnancy loss can easily be made based on characteristic clinical features and the absence of any POC on ultrasound.<xref ref-type="bibr" rid="article-29399.r5">[5]</xref> For pregnancies at gestational ages too early to visualize fetal cardiac activity, typically less than 6 weeks of gestation, documentation of falling hCG levels over 48 to 72 hours may assist with diagnosis.<xref ref-type="bibr" rid="article-29399.r5">[5]</xref> The stages of early pregnancy loss and their possible associated findings are detailed in the Table.</p>
        <table-wrap id="article-29399.table0" position="float" orientation="portrait">
          <caption>
            <title>Table. Diagnostic Findings Associated With Different Types of Early Pregnancy Loss&#x000a0;[27]</title>
          </caption>
          <table style="width: 756px;" border="1" cellspacing="0" cellpadding="5">
            <tbody>
              <tr style="height: 13px;">
                <td style="width: 126px; height: 13px;" rowspan="1" colspan="1">
<bold>Diagnosis</bold>
</td>
                <td style="width: 148px; height: 13px;" rowspan="1" colspan="1">
<bold>History</bold>
</td>
                <td style="width: 148.172px; height: 13px;" rowspan="1" colspan="1">
<bold>Physical exam findings</bold>
</td>
                <td style="width: 146.828px; height: 13px;" rowspan="1" colspan="1">
<bold>Ultrasound findings</bold>
</td>
              </tr>
              <tr style="height: 48px;">
                <td style="width: 126px; height: 48px;" rowspan="1" colspan="1">
<bold>Threatened pregnancy loss</bold>
</td>
                <td style="width: 148px; height: 48px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Bleeding</p></list-item><list-item><p>Cramping</p></list-item></list>
</td>
                <td style="width: 148.172px; height: 48px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Cervical os closed</p></list-item></list>
</td>
                <td style="width: 146.828px; height: 48px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Viable IUP consistent with gestational age</p></list-item><list-item><p>Subchorionic hemorrhage may or may not be present</p></list-item></list>
</td>
              </tr>
              <tr style="height: 48px;">
                <td style="width: 126px; height: 48px;" rowspan="1" colspan="1">
<bold>Inevitable pregnancy loss&#x000a0;</bold>
</td>
                <td style="width: 148px; height: 48px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Bleeding</p></list-item><list-item><p>Cramping</p></list-item></list>
</td>
                <td style="width: 148.172px; height: 48px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Cervical os open</p></list-item><list-item><p>POC visible at the cervical os</p></list-item></list>
</td>
                <td style="width: 146.828px; height: 48px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Intrauterine POC present</p></list-item><list-item><p>FCA may or may not be noted</p></list-item></list>
</td>
              </tr>
              <tr style="height: 74px;">
                <td style="width: 126px; height: 74px;" rowspan="1" colspan="1">
<bold>Incomplete p<bold>regnancy loss&#x000a0;</bold></bold>
</td>
                <td style="width: 148px; height: 74px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Bleeding</p></list-item><list-item><p>Cramping</p></list-item><list-item><p>Expulsion of tissue/clots</p></list-item></list>
</td>
                <td style="width: 148.172px; height: 74px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Cervical os open</p></list-item><list-item><p>POC may be visible at the cervical os</p></list-item></list>
</td>
                <td style="width: 146.828px; height: 74px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Heterogenic and echogenic areas within the uterus and endocervical canal indicative of remnant intrauterine POC</p></list-item></list>
</td>
              </tr>
              <tr style="height: 87px;">
                <td style="width: 126px; height: 87px;" rowspan="1" colspan="1">
<bold>Complete p<bold>regnancy loss&#x000a0;</bold></bold>
</td>
                <td style="width: 148px; height: 87px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Resolution of bleeding and cramping</p></list-item><list-item><p>Reported passage of tissue/clots by patient</p></list-item></list>
</td>
                <td style="width: 148.172px; height: 87px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Cervical os closed</p></list-item></list>
</td>
                <td style="width: 146.828px; height: 87px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Absence of gestational sac or other POC</p></list-item><list-item><p>Thickened endometrial lining may be visualized</p></list-item></list>
</td>
              </tr>
              <tr style="height: 18.5px;">
                <td style="width: 126px; height: 18.5px;" rowspan="1" colspan="1">
<bold>
<bold>Asymptomatic pregnancy loss&#x000a0;</bold>
</bold>
</td>
                <td style="width: 148px; height: 18.5px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Asymptomatic</p></list-item><list-item><p>Regression of common pregnancy symptoms may be reported</p></list-item></list>
</td>
                <td style="width: 148.172px; height: 18.5px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Cervical os closed</p></list-item></list>
</td>
                <td style="width: 146.828px; height: 18.5px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Diagnostic findings of pregnancy failure<sup>a</sup></p></list-item></list>
</td>
              </tr>
              <tr style="height: 52px;">
                <td style="width: 126px; height: 52px;" rowspan="1" colspan="1">
<p><bold>Septic m</bold><bold><bold>iscarriage</bold></bold></p>
</td>
                <td style="width: 148px; height: 52px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Bleeding</p></list-item><list-item><p>Cramping pelvic pain</p></list-item><list-item><p>Fever</p></list-item><list-item><p>Attempted self-induced abortion</p></list-item></list>
</td>
                <td style="width: 148.172px; height: 52px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Significant uterine tenderness to palpation</p></list-item><list-item><p>Purulent discharge</p></list-item><list-item><p>Signs of sepsis</p></list-item></list>
</td>
                <td style="width: 146.828px; height: 52px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Variable; may include heterogenic and echogenic areas of retained POC and exudative fluid</p></list-item></list>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>FCA, fetal cardiac activity, IUP, intrauterine pregnancy; PE, physical exam; POC, products of conception.</p>
        <p><sup>a</sup>See Early Intrauterine Pregnancies of Unknown Viability.</p>
        <p>
<bold>Early Intrauterine Pregnancies of Unknown Viability</bold>
</p>
        <p>For pregnancies at gestational ages too early to visualize fetal cardiac activity (FCA), typically less than 6 weeks of gestation, documentation of falling &#x003b2;-hCG levels over 48 to 72 hours may assist with the diagnosis of early pregnancy loss.<xref ref-type="bibr" rid="article-29399.r5">[5]</xref>&#x000a0;Even before FCA develops, ultrasound can help establish pregnancy viability, though it may require multiple scans over several weeks. Early pregnancy events follow a sequential pattern, and any variation from this sequence may suggest early pregnancy loss. For example, on ultrasound, the visualization of the yolk sac follows the appearance of the gestational sac, which is then closely followed by the presence of an embryo with cardiac activity. Therefore, ultrasound imaging of a gestational sac with a mean sac diameter (MSD) of at least 25 mm, a demonstration of an embryo would be expected. Moreover, a detectable fetal heart rate should be present with an embryo with a crown-rump length (CRL) of at least 7 mm.<xref ref-type="bibr" rid="article-29399.r5">[5]</xref></p>
        <p>A multispecialty panel from the Society of Radiologists in Ultrasound released guidelines based on ultrasound findings for diagnosing intrauterine pregnancy failure. These guidelines, reaffirmed by ACOG, include findings diagnostic of pregnancy failure and those suspicious for, but not diagnostic of, pregnancy failure.<xref ref-type="bibr" rid="article-29399.r29">[29]</xref><xref ref-type="bibr" rid="article-29399.r5">[5]</xref></p>
        <p>
<bold>Findings consistent with a pregnancy failure diagnosis</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>CRL &#x02265;7 mm without FCA</p>
          </list-item>
          <list-item>
            <p>MSD &#x02265;25 mm without an embryo</p>
          </list-item>
          <list-item>
            <p>Absence of an embryo with&#x000a0;FCA&#x000a0;&#x02265;14 days following an ultrasound demonstrating a gestational sac without a yolk sac</p>
          </list-item>
          <list-item>
            <p>Absence of an embryo with&#x000a0;FCA &#x02265;11 days&#x000a0;following an ultrasound demonstrating a gestational sac with a yolk sac</p>
          </list-item>
        </list>
        <p>
<bold>Findings that raise suspicion of pregnancy failure but are not conclusive for diagnosis</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>CRL of &#x0003c;7 mm without FCA</p>
          </list-item>
          <list-item>
            <p>MSD of 16 to 24 mm without an embryo</p>
          </list-item>
          <list-item>
            <p>Absence of an embryo with FCA 7 to 13 days following an ultrasound demonstrating a gestational sac without a yolk sac</p>
          </list-item>
          <list-item>
            <p>Absence of an embryo with&#x000a0;FCA 7 to 10 days following an ultrasound demonstrating a gestational sac with a yolk sac</p>
          </list-item>
          <list-item>
            <p>Absence of an embryo &#x02265;6 weeks since the LMP</p>
          </list-item>
          <list-item>
            <p>Empty amnion (ie, amnion seen adjacent to a yolk sac with no visible embryo)</p>
          </list-item>
          <list-item>
            <p>Enlarged yolk sac &#x0003e;7 mm</p>
          </list-item>
          <list-item>
            <p>Small gestational sac compared to the size of the embryo (ie, &#x0003c;5 mm difference between the MSD and CRL)</p>
          </list-item>
        </list>
        <p>If the viability of an intrauterine pregnancy is uncertain (eg, ultrasound findings are nondiagnostic of pregnancy failure or signs of threatened pregnancy loss are present), the ultrasound should be repeated in 7 to 10 days.<xref ref-type="bibr" rid="article-29399.r5">[5]</xref></p>
        <p>
<bold>Early Pregnancies of Unknown Location</bold>
</p>
        <p>When the location of a fertilized egg is unknown at the time of presentation (ie,&#x000a0;fetal or embryonic structures are&#x000a0;<italic toggle="yes">not</italic> seen on the initial ultrasound), the immediate step is to determine the gestational age and location of the&#x000a0;fertilized egg to exclude an ectopic pregnancy. This typically requires trending&#x000a0;&#x003b2;-hCG levels over several days.<xref ref-type="bibr" rid="article-29399.r3">[3]</xref></p>
        <p>Initially, the estimated due date (EDD) is determined based on an accurate LMP. This estimate is then compared to the EDD, calculated using ultrasound for confirmation. ACOG states that "accurate gestational age calculation, rather than an absolute&#x000a0;&#x003b2;-hCG level, is the best determinant of when a normal pregnancy should be seen within the uterus with transvaginal ultrasonography" and notes that the gestational sac and yolk sac should be visible between 5 and 6 weeks of gestation, regardless of the number of embryos present.<xref ref-type="bibr" rid="article-29399.r30">[30]</xref>&#x000a0;Irregularities in the menstrual cycle, however, can impact the timing of ovulation and conception relative to the LMP, which is why it is crucial to consider the entire clinical picture&#x000a0;during evaluation and not to rely solely on either the LMP-derived due date or a single &#x003b2;-hCG level. Therefore, the first &#x003b2;-hCG level primarily provides a secondary guide on the pregnancy development that should be expected on ultrasound. Serial &#x003b2;-hCG levels, if needed, can then be monitored for the average increase characteristic of a developing intrauterine pregnancy.<xref ref-type="bibr" rid="article-29399.r5">[5]</xref></p>
        <p>The concept of a discriminatory level may be useful in assessing pregnancy location, but similarly, it should be applied with care and in the context of the full clinical picture. The discriminatory level refers to the &#x003b2;-hCG level at which the gestational sac should be visible on transvaginal sonography; if the &#x003b2;-hCG level is above the discriminatory level cut-off and a gestational sac is <italic toggle="yes">not</italic> seen in the uterus, ectopic pregnancy should be suspected.<xref ref-type="bibr" rid="article-29399.r5">[5]</xref><xref ref-type="bibr" rid="article-29399.r3">[3]</xref><xref ref-type="bibr" rid="article-29399.r29">[29]</xref><xref ref-type="bibr" rid="article-29399.r28">[28]</xref>&#x000a0;To avoid misdiagnosis of a potentially viable intrauterine pregnancy, ACOG recommends using a cut-off with a conservatively high&#x000a0;&#x003b2;-hCG level, such as 3,500 mIU/mL, which is a higher value than what has been recommended in the past, to aid in diagnosis.<xref ref-type="bibr" rid="article-29399.r30">[30]</xref>&#x000a0;Multiple gestations, for example, will have relatively higher &#x003b2;-hCG levels than singletons at a given gestational age.</p>
        <p>While the&#x000a0;location of the pregnancy remains uncertain, patients should be closely followed until the location is definitively identified (ie, a yolk sac and fetal pole are seen within the gestational sac). This is done by trending &#x003b2;-hCG levels every 48 to 72 hours, with periodic repeat ultrasound assessments (often done at the same time as the repeat &#x003b2;-hCG levels) until the location is confidently identified on ultrasound or &#x003b2;-hCG levels fall to nonpregnant levels (ie, 0).<xref ref-type="bibr" rid="article-29399.r5">[5]</xref><xref ref-type="bibr" rid="article-29399.r3">[3]</xref><xref ref-type="bibr" rid="article-29399.r29">[29]</xref><xref ref-type="bibr" rid="article-29399.r28">[28]</xref>&#x000a0;It is important to remember that hormonal changes associated with ectopic pregnancy can result in the formation of an intrauterine fluid collection. However, this is not a true gestational sac; this is why visualization of embryonic structures is essential to identify the developing embryo's location accurately.&#x000a0;</p>
        <p>In the setting of a viable pregnancy, &#x003b2;-hCG levels increase at a relatively predictable rate. However, as the &#x003b2;-hCG level increases, its rate of increase gradually slows until it reaches a plateau around 10 weeks of gestation. The minimum rates of &#x003b2;-hCG rise expected over 48 hours are 49%, 40%, and 33% for initial &#x003b2;-hCG levels of&#x000a0;&#x0003c;1,500 mIU/mL, 1,500 to 3,000 mIU/mL, and &#x0003e;3,000 mIU/mL, respectively.<xref ref-type="bibr" rid="article-29399.r31">[31]</xref>&#x000a0;If the &#x003b2;-hCG level fails to meet the minimum expected rate of rise, ectopic pregnancy should be strongly considered. Falling &#x003b2;-hCG levels typically indicate failing pregnancies. However, ectopic pregnancies can have an initial decrease in &#x003b2;-hCG followed by an abnormal increase. Therefore, if the pregnancy location has not been confidently identified on ultrasound, the &#x003b2;-hCG level should be monitored until nonpregnant levels are reached to ensure an ectopic pregnancy is not missed.<xref ref-type="bibr" rid="article-29399.r32">[32]</xref></p>
      </sec>
      <sec id="article-29399.s7" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Early pregnancy loss can be managed expectantly, medically, or surgically.&#x000a0;Certain clinical factors may make one management strategy preferable, though all 3 modalities can often be considered.&#x000a0;Studies show that patients managed according to their preferences have better mental health outcomes and are more satisfied with their care.<xref ref-type="bibr" rid="article-29399.r5">[5]</xref><xref ref-type="bibr" rid="article-29399.r33">[33]</xref>&#x000a0;However, it is important to note that&#x000a0;regional guidelines can vary, which is discussed in further detail below.&#x000a0;</p>
        <p>
<bold>Expectant and Medical Management</bold>
</p>
        <p><bold>Contraindications:</bold>&#x000a0;Hemorrhage and infection are contraindications to expectant and medical management. Additionally, expectant management is relatively contraindicated after the first trimester due to a lack of safety data. Expectant and medical management are typically less favored in patients who cannot tolerate heavier bleeding, including patients with severe anemia, bleeding disorders, and cardiovascular disease.<xref ref-type="bibr" rid="article-29399.r5">[5]</xref>&#x000a0;</p>
        <p><bold>Efficacy:</bold>&#x000a0;Expectant management may be continued safely for as long as the patient desires, provided infection and hemorrhage do not develop.<xref ref-type="bibr" rid="article-29399.r3">[3]</xref>&#x000a0;Approximately 70% of early pregnancy losses will have complete expulsion within one month and up to 80% within 2 months.<xref ref-type="bibr" rid="article-29399.r3">[3]</xref><xref ref-type="bibr" rid="article-29399.r5">[5]</xref> Expectant management appears more effective in symptomatic patients (eg, incomplete loss) than in asymptomatic patients (eg, missed abortion).<xref ref-type="bibr" rid="article-29399.r5">[5]</xref>&#x000a0;Furthermore, expectant and medical management are as effective as uterine aspiration in patients with first-trimester incomplete pregnancy losses.<xref ref-type="bibr" rid="article-29399.r11">[11]</xref></p>
        <p><bold>Medications:</bold>&#x000a0;Misoprostol is the primary drug used to manage early pregnancy loss. Although numerous different misoprostol regimens have been used, the regimen currently recommended by ACOG consists of misoprostol 800 mcg vaginally once daily as a single dose; if the expulsion of POC does not occur, the dose may be repeated once, any time from 3 hours to 7 days after the first dose.&#x000a0;Premedication with mifepristone 200 mg orally once daily as a single dose, 24 hours before the first dose of misoprostol, results in a higher success rate than misoprostol alone and is recommended by most experts, if available.<xref ref-type="bibr" rid="article-29399.r3">[3]</xref><xref ref-type="bibr" rid="article-29399.r5">[5]</xref></p>
        <p>A 2018 randomized controlled trial published in <italic toggle="yes">The New England Journal of Medicine</italic>&#x000a0;included 300 women with early pregnancy loss compared with a combined mifepristone-misoprostol regimen (mifepristone 200 mg orally followed 24 hours later with misoprostol 800 mcg vaginally for 1-2 doses) to misoprostol alone (800 mcg vaginally for 1-2 doses). This study showed that adding mifepristone to misoprostol resulted in significantly higher rates of complete miscarriage resolution (91% vs 75%) and lower rates of needed surgical intervention (9% vs 24%). Rates of serious adverse events, defined as pelvic infection or bleeding resulting in blood transfusion, were similar in both groups.<xref ref-type="bibr" rid="article-29399.r34">[34]</xref>&#x000a0;Common adverse effects included vaginal bleeding, cramping, diarrhea, and nausea.<xref ref-type="bibr" rid="article-29399.r3">[3]</xref>&#x000a0;Oxytocin is ineffective for managing early pregnancy loss since oxytocin receptors are absent within the uterus until after the first trimester.<xref ref-type="bibr" rid="article-29399.r35">[35]</xref>&#x000a0;In addition to medications offered to assist in the expulsion of POC, patients should also be provided with appropriate pain control. Nonsteroidal anti-inflammatory drugs (NSAIDs) are typically effective, though some patients may require additional agents. Antibiotics are not indicated unless an infection is present.<xref ref-type="bibr" rid="article-29399.r5">[5]</xref></p>
        <p><bold>Documenting completion:</bold>&#x000a0;Although there is a lack of consensus, complete pregnancy loss is often defined as the absence of a gestational sac on ultrasound with an endometrial thickness of &#x0003c;30 mm. This ultrasound is usually performed 7 to 14 days after the initiation of medical management or at follow-up visits every 1&#x000a0;to 2 weeks in patients being managed expectantly. However, it is important to note that&#x000a0;ACOG&#x000a0;states, "surgical intervention is not required in asymptomatic women with a thickened endometrial stripe after treatment for early pregnancy loss. Thus, the use of ultrasound examination for any diagnostic purpose other than documenting the absence of the gestational sac is not recommended."<xref ref-type="bibr" rid="article-29399.r5">[5]</xref>&#x000a0;Patient-reported resolution of cramps and bleeding is also useful in confirming complete abortion.<xref ref-type="bibr" rid="article-29399.r5">[5]</xref>&#x000a0;&#x003b2;-hCG levels do not need to be followed to 0 mIU/mL unless the location of the pregnancy within the pelvis remains unknown or if persistent bleeding and constitutional symptoms of malignancy raise suspicion for gestational trophoblastic disease; however, serial levels may be used if ultrasound confirmation is not available.<xref ref-type="bibr" rid="article-29399.r5">[5]</xref><xref ref-type="bibr" rid="article-29399.r36">[36]</xref>&#x000a0;Regardless of the management approach, patients should be counseled to return for evaluation if bleeding is excessive.<xref ref-type="bibr" rid="article-29399.r5">[5]</xref> This is often defined as soaking more than one menstrual pad per hour for 2 consecutive hours.<xref ref-type="bibr" rid="article-29399.r5">[5]</xref><xref ref-type="bibr" rid="article-29399.r3">[3]</xref></p>
        <p><bold>Alloimmunization:</bold>&#x000a0;Finally, there is a risk of alloimmunization in unsensitized Rh(D)-negative patients, though this risk is low, especially in very early pregnancy before the development of fetal erythrocytes.<xref ref-type="bibr" rid="article-29399.r37">[37]</xref>&#x000a0;ACOG recommends giving Rh(D)-immune globulin to&#x000a0;unsensitized Rh(D)-negative patients with early pregnancy loss, especially those later in the first trimester. The recommendations of professional societies from other countries, however, differ from those from the United States (US) slightly; for example, the National Institute for Health and Care Excellence (NICE) guidelines from the United Kingdom (UK) explicitly state that Rh(D)-immune globulin is&#x000a0;not indicated for nonsurgical management of miscarriage in the first trimester.<xref ref-type="bibr" rid="article-29399.r5">[5]</xref>&#x000a0;If given, Rh(D)-immune globulin 50 to 120 mcg once is recommended in the first trimester and 300 mcg once in the second trimester.<xref ref-type="bibr" rid="article-29399.r37">[37]</xref></p>
        <p>
<bold>Surgical Management</bold>
</p>
        <p>Surgical management is indicated in all patients with contraindications to expectant and medical management, including patients with hemodynamic instability, uterine hemorrhage, or septic miscarriages, who all require emergent uterine evacuation. Nonemergent surgical management is indicated in patients who would not tolerate heavy bleeding, including those with severe anemia, cardiovascular disease, and bleeding disorders.<xref ref-type="bibr" rid="article-29399.r5">[5]</xref>&#x000a0;</p>
        <p>In the first trimester, surgical management consists of uterine aspiration or dilation and suction curettage, with sharp curettage as needed. These procedures may be performed in the operating room or office setting. There is evidence that suction curettage alone, without sharp curettage, is sufficient and decreases the risk of intrauterine adhesions as long as there is reasonable certainty that the uterus is empty.<xref ref-type="bibr" rid="article-29399.r5">[5]</xref>&#x000a0;Although rare, risks of&#x000a0;surgical management include cervical laceration, uterine perforation, and the development of intrauterine adhesions, which are more common in the setting of infection.&#x000a0;ACOG recommends a single preoperative dose of prophylactic antibiotics in patients managed surgically. A common regimen is doxycycline 200 mg orally once daily, as a single dose, 1 hour before uterine evacuation.<xref ref-type="bibr" rid="article-29399.r5">[5]</xref>&#x000a0;Additionally, all Rh(D)-negative patients undergoing surgical uterine evacuation should receive Rh(D)-immune globulin prophylaxis to prevent alloimmunization, regardless of gestational age, due to the higher risk of alloimmunization with uterine instrumentation.<xref ref-type="bibr" rid="article-29399.r5">[5]</xref><xref ref-type="bibr" rid="article-29399.r37">[37]</xref></p>
        <p>
<bold>Choosing a Management Strategy</bold>
</p>
        <p>As previously discussed, certain patient-specific factors, such as hemorrhage or infection at presentation, or the presence of comorbidities, such as bleeding disorders or cardiovascular disease, are all indications for surgical management. Commonly, however, none of these factors are present. Generally, in these cases, all 3 options can be discussed with the patient, and her informed decision should be honored, though national guidelines can vary. For example, the UK NICE guidelines prefer to offer patients with first-trimester pregnancy loss a 1- to 2-week trial of expectant or medical management before offering them surgical management. In contrast, ACOG guidelines in the US note that all 3 management options are acceptable first-line treatments, and patient preference should guide management. Due to their uncertain nature, threatened and biochemical pregnancy losses should be managed expectantly.<xref ref-type="bibr" rid="article-29399.r5">[5]</xref></p>
        <p>Regarding patient preference, some patients may prefer a more "natural" approach and be willing to wait up to 4 to 8 weeks for miscarriage resolution, while others may desire the immediate and definitive nature of surgical management. Some patients may prefer the control, expedited results, and higher success rates associated with medical management over expectant management.&#x000a0;In multigravida patients, prior experience can also contribute significantly to their preferences. Additionally, the types of pregnancy loss (eg, asymptomatic or incomplete) should also be discussed with the patient, as differences in success rates with expectant versus medical management may also impact how a patient desires to proceed.<xref ref-type="bibr" rid="article-29399.r38">[38]</xref><xref ref-type="bibr" rid="article-29399.r33">[33]</xref></p>
        <p>
<bold>Management of Septic Abortion</bold>
</p>
        <p>The first step is to assess hemodynamic stability and provide appropriate emergency resuscitation as needed. Initiate empiric broad-spectrum IV antibiotics and IV fluids as soon as possible. The selection of empiric IV antibiotics should be individualized, considering patient factors (eg, allergies, comorbidities), local susceptibility trends, and cost. Regimens include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Ampicillin 2 g IV every 4 hours, PLUS gentamicin 5 mg/kg daily IV PLUS metronidazole 500 mg IV every 8 hours&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Ampicillin 2 g IV every 4 hours PLUS gentamicin 5 mg/kg daily IV PLUS clindamycin 900 mg IV every 8 hours</p>
          </list-item>
          <list-item>
            <p>Piperacillin + tazobactam 4.5 g IV every 8 hours with or without vancomycin</p>
          </list-item>
          <list-item>
            <p>Imipenem&#x000a0;+ cilastatin 500 mg IV every 6 hours</p>
          </list-item>
          <list-item>
            <p>Cefepime or ceftazidime 2 g IV every 8 hours PLUS metronidazole 500 mg IV every 8 hours</p>
          </list-item>
          <list-item>
            <p>Levofloxacin 500 mg IV daily PLUS metronidazole 500 mg IV every 8 hours&#x000a0;<xref ref-type="bibr" rid="article-29399.r39">[39]</xref><xref ref-type="bibr" rid="article-29399.r40">[40]</xref></p>
          </list-item>
        </list>
        <p>Following stabilization and IV fluid resuscitation efforts and the initiation of antibiotics, the primary treatment of a septic abortion is the prompt surgical evacuation of the uterus, which is the source of the infection.<xref ref-type="bibr" rid="article-29399.r41">[41]</xref>&#x000a0;Septic abortion can be associated with significant complications, including sepsis, disseminated intravascular coagulation, toxic shock, acute renal injury, acute respiratory distress, and necrotizing fasciitis. Therefore, patients should be frequently monitored for evidence of clinical improvement (eg, decreasing uterine tenderness, afebrile for a minimum of 24 hours). Consultation with an infectious disease specialist is also recommended.<xref ref-type="bibr" rid="article-29399.r41">[41]</xref>&#x000a0;Once clinical improvement is documented, patients can be switched to oral antibiotic therapy for 10 to 14 days.<xref ref-type="bibr" rid="article-29399.r41">[41]</xref></p>
        <p>
<bold>Contraception</bold>
</p>
        <p>In patients who desire it, hormonal contraception may be initiated directly following the complete resolution of an early pregnancy loss. An intrauterine device may be placed immediately after surgical evacuation of the uterus, which is only contraindicated in the setting of intrauterine infection.<xref ref-type="bibr" rid="article-29399.r5">[5]</xref></p>
      </sec>
      <sec id="article-29399.s8" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis of early pregnancy loss primarily involves consideration of the underlying etiologies of vaginal bleeding early in pregnancy, including:</p>
        <list list-type="bullet">
          <list-item>
            <p>Ectopic pregnancy can also cause cramping, vaginal bleeding, and an abnormal rise&#x000a0;of &#x003b2;-hCG in early pregnancy; an extrauterine mass may also be seen on ultrasound.</p>
          </list-item>
          <list-item>
            <p>Subchorionic hematoma, commonly presenting with vaginal bleeding, may cause threatened miscarriage and can progress to pregnancy loss.</p>
          </list-item>
          <list-item>
            <p>Gestational trophoblastic disease can present with signs and symptoms such as bleeding in pregnancy, a uterine size larger than expected for gestational age, abnormally high &#x003b2;-hCG levels, and hyperemesis gravidarum; ultrasound may demonstrate a diffuse mixed echogenic pattern within the uterus and cystic enlargement of the maternal ovaries.</p>
          </list-item>
          <list-item>
            <p>Cervical and vaginal pathologies (eg, infectious cervicitis, cervical polyps, ectropion, dysplasia, or trauma) should be considered, especially in the setting of postcoital or contact bleeding.</p>
          </list-item>
          <list-item>
            <p>Implantation or idiopathic bleeding of pregnancy should only be diagnoses of exclusion.</p>
          </list-item>
        </list>
        <p>These differential diagnoses can usually be sufficiently evaluated through history, physical exam, and pelvic ultrasound.<xref ref-type="bibr" rid="article-29399.r5">[5]</xref></p>
      </sec>
      <sec id="article-29399.s9" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Severe complications of early pregnancy loss, including hypovolemic shock and septic miscarriage, are rare. Because complication rates are similarly low for expectant, medical, and surgical management,&#x000a0;the prognosis of&#x000a0;early pregnancy loss is typically good.<xref ref-type="bibr" rid="article-29399.r5">[5]</xref>&#x000a0;However, hemorrhage and infection due to miscarriage can contribute to maternal mortality, especially in low-income countries, where the social determinants of health decrease access to high-quality obstetrical care.<xref ref-type="bibr" rid="article-29399.r11">[11]</xref>&#x000a0;</p>
        <p>Additionally, the weeks to months after a miscarriage are often accompanied by feelings of grief, guilt, anxiety, and depression for both the patient and her partner, especially in cases of recurrent loss, fertility challenges, loss of a highly desired pregnancy, and in patients with pre-existing mental health concerns. Although there is limited evidence for the effectiveness of psychological counseling in this setting, patients and their families will likely experience better outcomes if these emotions and feelings are addressed early.<xref ref-type="bibr" rid="article-29399.r42">[42]</xref>&#x000a0;Attempting conception immediately after resolution of early pregnancy loss is safe, and couples who attempt conception within 3 months after miscarriage experience higher rates of successful pregnancy and live birth than those who postpone conception.<xref ref-type="bibr" rid="article-29399.r43">[43]</xref><xref ref-type="bibr" rid="article-29399.r44">[44]</xref>&#x000a0;</p>
        <p>Recurrent pregnancy loss can vary slightly but is often defined as the spontaneous loss of 2 to 3 pregnancies. Fewer than 5% of patients are estimated to experience 2 consecutive losses, while only 1% will experience 3 or more.<xref ref-type="bibr" rid="article-29399.r45">[45]</xref> A workup is recommended in these patients to look for an underlying cause. This workup generally includes genetic analysis of both parents and maternal assessment for hormonal anomalies, uterine anomalies, and antiphospholipid syndrome.<xref ref-type="bibr" rid="article-29399.r22">[22]</xref>&#x000a0;Recurrent pregnancy loss is discussed in more detail elsewhere.<xref ref-type="bibr" rid="article-29399.r46">[46]</xref></p>
      </sec>
      <sec id="article-29399.s10" sec-type="Complications">
        <title>Complications</title>
        <p>Complications of&#x000a0;early pregnancy loss include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Retained&#x000a0;POC</p>
          </list-item>
          <list-item>
            <p>Hemorrhage and subsequent complications secondary to hypovolemia</p>
          </list-item>
          <list-item>
            <p>Infection</p>
          </list-item>
          <list-item>
            <p>Traumatic complications of surgical management (eg, cervical laceration and uterine perforation)</p>
          </list-item>
          <list-item>
            <p>DIC</p>
          </list-item>
          <list-item>
            <p>Postabortion triad (ie, low-grade fever, pain, and bleeding)</p>
          </list-item>
          <list-item>
            <p>Hematometra</p>
          </list-item>
          <list-item>
            <p>Cervical shock&#x000a0;
<list list-type="bullet"><list-item><p>A rare complication of incomplete pregnancy loss in which POC within the cervical canal causes a vagal response leading to clinically significant hypotension and bradycardia that does not respond to IV fluids.</p></list-item><list-item><p>Typically, it resolves quickly after the removal of POC from the cervix at the bedside.<xref ref-type="bibr" rid="article-29399.r47">[47]</xref></p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Complications secondary to septic miscarriage (eg, sepsis syndrome, DIC, toxic shock syndrome, acute renal injury, acute respiratory distress syndrome, necrotizing fasciitis, and future infertility due to scarring of the fallopian tubes&#x000a0;<xref ref-type="bibr" rid="article-29399.r14">[14]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-29399.s11" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Pregnant individuals should be counseled on avoiding the modifiable risk factors for miscarriage, such as tobacco and cocaine use, and encouraged to optimize nutrition. However, limited evidence supports the use of any single prevention strategy. Pelvic rest, tocolytics, anticoagulants, and supplemental &#x003b2;-hCG have not been shown in studies to decrease the risk of early pregnancy loss. Aspirin and anticoagulants have only been shown to reduce the rate of spontaneous pregnancy loss in women with antiphospholipid syndrome. Likewise, supplemental progesterone has only been shown to prevent early pregnancy loss in patients with recurrent pregnancy loss.<xref ref-type="bibr" rid="article-29399.r5">[5]</xref></p>
      </sec>
      <sec id="article-29399.s12" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Highlighted&#x000a0;facts pertinent&#x000a0;to early pregnancy loss&#x000a0;are listed below.</p>
        <list list-type="bullet">
          <list-item>
            <p>Early pregnancy loss&#x000a0;is generally defined as a spontaneous pregnancy loss before&#x000a0;10 to 13 weeks of gestational age.<xref ref-type="bibr" rid="article-29399.r5">[5]</xref></p>
          </list-item>
          <list-item>
            <p>Approximately half of&#x000a0;all early pregnancy loss is&#x000a0;due to unknown genetic abnormalities.<xref ref-type="bibr" rid="article-29399.r5">[5]</xref></p>
          </list-item>
          <list-item>
            <p>The most common risk factors are advancing maternal age and previous early pregnancy loss. Alcohol or drug use, some infections, chronic disease, environmental exposures, and structural uterine abnormalities are other potential risk factors.<xref ref-type="bibr" rid="article-29399.r5">[5]</xref></p>
          </list-item>
          <list-item>
            <p>Symptoms and signs of early pregnancy loss depend on the type of pregnancy loss but generally include bleeding and menstrual-like cramping in the first half of pregnancy.<xref ref-type="bibr" rid="article-29399.r5">[5]</xref></p>
          </list-item>
          <list-item>
            <p>Types of pregnancy loss include missed, threatened, inevitable, incomplete, complete, recurrent, and septic miscarriage.</p>
          </list-item>
          <list-item>
            <p>The evaluation usually involves a thorough history and physical exam, pelvic ultrasound, and &#x003b2;-HCG measurement.<xref ref-type="bibr" rid="article-29399.r5">[5]</xref></p>
          </list-item>
          <list-item>
            <p>Although management also depends on the type of miscarriage, expectant, medical, and surgical approaches are generally equally effective.&#x000a0;Patients are more satisfied with their care and have better mental health outcomes when managed in accordance with their preferences.<xref ref-type="bibr" rid="article-29399.r5">[5]</xref></p>
          </list-item>
          <list-item>
            <p>Medical management of early pregnancy loss is best achieved with a combination of misoprostol and mifepristone, though it can also be managed with misoprostol alone if mifepristone is unavailable.<xref ref-type="bibr" rid="article-29399.r5">[5]</xref></p>
          </list-item>
          <list-item>
            <p>Surgical management of miscarriage is indicated in cases of hemorrhage, infection, and patients with comorbidities that may lead to complications if significant&#x000a0;heavy bleeding occurs (eg, severe anemia, cardiovascular disease, and bleeding disorders).<xref ref-type="bibr" rid="article-29399.r5">[5]</xref></p>
          </list-item>
          <list-item>
            <p>Only aspirin in the setting of antiphospholipid syndrome and supplemental progesterone in the context of recurrent miscarriage have demonstrated the potential for reducing the risk of early pregnancy loss.<xref ref-type="bibr" rid="article-29399.r5">[5]</xref></p>
          </list-item>
          <list-item>
            <p>Testing for genetic abnormalities and antiphospholipid syndrome should generally be reserved for recurrent early pregnancy loss cases.<xref ref-type="bibr" rid="article-29399.r5">[5]</xref></p>
          </list-item>
          <list-item>
            <p>Attempting pregnancy immediately following the complete resolution of early pregnancy loss is safe.<xref ref-type="bibr" rid="article-29399.r5">[5]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-29399.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Since&#x000a0;early pregnancy loss can occur across multiple settings (eg, at home or in a clinic, urgent care, or&#x000a0;hospital setting), team-based care is essential. Emergency department clinicians must ensure the seamless transfer of medical records, including relevant labs and imaging, to outpatient clinics for appropriate follow-up, which is often required. In the outpatient setting, convenient scheduling of frequent, appropriately timed appointments is critical, as well as providing patients with clear instructions on when to present to the clinic versus the emergency department for persistent symptoms. Finally, although the medical aspects of miscarriage management can be complicated, the patient's and her family's psychological well-being cannot be neglected.</p>
        <p>Nursing staff often help with patient education, phone triage, scheduling, arranging follow-up, and emotional support at the bedside.&#x000a0;Radiology technicians need to be familiar with the diagnostic criteria for early pregnancy loss to ensure all appropriate structures are adequately analyzed so that clinicians can make an accurate diagnosis. Frequently, patients have a follow-up &#x003b2;-hCG level drawn and then are seen by a clinician to review their results and discuss their care plan. Therefore, lab personnel must promptly process and report the findings to avoid delays in patient care.&#x000a0;Medical assistants can assist clinicians by knowing that patients coming in for follow-up of early pregnancy loss may require a bedside ultrasound and have one readily available, as well as being emotionally supportive to patients during their visit.</p>
      </sec>
      <sec id="article-29399.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29399&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29399">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/womens-health/early-pregnancy-loss-spontaneous-abortion-miscarriage/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=29399">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/29399/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=29399">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-29399.s15">
        <title>References</title>
        <ref id="article-29399.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clement</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Horvath</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>McAllister</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Koelper</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Sammel</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Schreiber</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>The Language of First-Trimester Nonviable Pregnancy: Patient-Reported Preferences and Clarity.</article-title>
            <source>Obstet Gynecol</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>133</volume>
            <issue>1</issue>
            <fpage>149</fpage>
            <page-range>149-154</page-range>
            <pub-id pub-id-type="pmid">30531561</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <collab>American College of Obstetricians and Gynecologists</collab>
            <collab>Society for Maternal-Fetal Medicine</collab>
            <article-title>Obstetric Care consensus No. 6: Periviable Birth.</article-title>
            <source>Obstet Gynecol</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>130</volume>
            <issue>4</issue>
            <fpage>e187</fpage>
            <page-range>e187-e199</page-range>
            <pub-id pub-id-type="pmid">28937572</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hendriks</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>MacNaughton</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>MacKenzie</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>First Trimester Bleeding: Evaluation and Management.</article-title>
            <source>Am Fam Physician</source>
            <year>2019</year>
            <month>Feb</month>
            <day>01</day>
            <volume>99</volume>
            <issue>3</issue>
            <fpage>166</fpage>
            <page-range>166-174</page-range>
            <pub-id pub-id-type="pmid">30702252</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharp</surname>
                <given-names>HT</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>JV</given-names>
              </name>
              <name>
                <surname>Lemieux</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Currigan</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Executive Summary of the reVITALize Initiative: Standardizing Gynecologic Data Definitions.</article-title>
            <source>Obstet Gynecol</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>129</volume>
            <issue>4</issue>
            <fpage>603</fpage>
            <page-range>603-607</page-range>
            <pub-id pub-id-type="pmid">28277367</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <collab>American College of Obstetricians and Gynecologists' Committee on Practice Bulletins&#x02014;Gynecology</collab>
            <article-title>ACOG Practice Bulletin No. 200: Early Pregnancy Loss.</article-title>
            <source>Obstet Gynecol</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>132</volume>
            <issue>5</issue>
            <fpage>e197</fpage>
            <page-range>e197-e207</page-range>
            <pub-id pub-id-type="pmid">30157093</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kolte</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Bernardi</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Christiansen</surname>
                <given-names>OB</given-names>
              </name>
              <name>
                <surname>Quenby</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Farquharson</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Goddijn</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Stephenson</surname>
                <given-names>MD</given-names>
              </name>
              <collab>ESHRE Special Interest Group, Early Pregnancy</collab>
            </person-group>
            <article-title>Terminology for pregnancy loss prior to viability: a consensus statement from the ESHRE early pregnancy special interest group.</article-title>
            <source>Hum Reprod</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>30</volume>
            <issue>3</issue>
            <fpage>495</fpage>
            <page-range>495-8</page-range>
            <pub-id pub-id-type="pmid">25376455</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Annan</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Gudi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bhide</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Homburg</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Biochemical pregnancy during assisted conception: a little bit pregnant.</article-title>
            <source>J Clin Med Res</source>
            <year>2013</year>
            <month>Aug</month>
            <volume>5</volume>
            <issue>4</issue>
            <fpage>269</fpage>
            <page-range>269-74</page-range>
            <pub-id pub-id-type="pmid">23864915</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wu</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Marwah</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>QM</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>XW</given-names>
              </name>
            </person-group>
            <article-title>Misoprostol for medical treatment of missed abortion: a systematic review and network meta-analysis.</article-title>
            <source>Sci Rep</source>
            <year>2017</year>
            <month>May</month>
            <day>10</day>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>1664</fpage>
            <pub-id pub-id-type="pmid">28490770</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhou</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Pan</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Leung</surname>
                <given-names>WT</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sima</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Qiu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>New thoughts in exploring the pathogenesis, diagnosis, and treatment of threatened abortion.</article-title>
            <source>Biosci Trends</source>
            <year>2019</year>
            <volume>13</volume>
            <issue>3</issue>
            <fpage>284</fpage>
            <page-range>284-285</page-range>
            <pub-id pub-id-type="pmid">31327799</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wahabi</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Fayed</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Esmaeil</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Bahkali</surname>
                <given-names>KH</given-names>
              </name>
            </person-group>
            <article-title>Progestogen for treating threatened miscarriage.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2018</year>
            <month>Aug</month>
            <day>06</day>
            <volume>8</volume>
            <issue>8</issue>
            <fpage>CD005943</fpage>
            <pub-id pub-id-type="pmid">30081430</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Barnard</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Neilson</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Hickey</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vazquez</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Dou</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Medical treatments for incomplete miscarriage.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2017</year>
            <month>Jan</month>
            <day>31</day>
            <volume>1</volume>
            <issue>1</issue>
            <fpage>CD007223</fpage>
            <pub-id pub-id-type="pmid">28138973</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <collab>Practice Committee of the American Society for Reproductive Medicine. Electronic address: asrm@asrm.org</collab>
            <article-title>Definitions of infertility and recurrent pregnancy loss: a committee opinion.</article-title>
            <source>Fertil Steril</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>113</volume>
            <issue>3</issue>
            <fpage>533</fpage>
            <page-range>533-535</page-range>
            <pub-id pub-id-type="pmid">32115183</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Larsen</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Christiansen</surname>
                <given-names>OB</given-names>
              </name>
              <name>
                <surname>Kolte</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Macklon</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>New insights into mechanisms behind miscarriage.</article-title>
            <source>BMC Med</source>
            <year>2013</year>
            <month>Jun</month>
            <day>26</day>
            <volume>11</volume>
            <fpage>154</fpage>
            <pub-id pub-id-type="pmid">23803387</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Udoh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Effa</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Oduwole</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Okusanya</surname>
                <given-names>BO</given-names>
              </name>
              <name>
                <surname>Okafo</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Antibiotics for treating septic abortion.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2016</year>
            <month>Jul</month>
            <day>01</day>
            <volume>7</volume>
            <issue>7</issue>
            <fpage>CD011528</fpage>
            <pub-id pub-id-type="pmid">27364644</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Neill</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Management of Early Pregnancy Loss.</article-title>
            <source>JAMA</source>
            <year>2023</year>
            <month>Apr</month>
            <day>25</day>
            <volume>329</volume>
            <issue>16</issue>
            <fpage>1399</fpage>
            <page-range>1399-1400</page-range>
            <pub-id pub-id-type="pmid">37027174</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jackson</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Watkins</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Early pregnancy loss.</article-title>
            <source>JAAPA</source>
            <year>2021</year>
            <month>Mar</month>
            <day>01</day>
            <volume>34</volume>
            <issue>3</issue>
            <fpage>22</fpage>
            <page-range>22-27</page-range>
            <pub-id pub-id-type="pmid">33528169</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Frazier</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hogue</surname>
                <given-names>CJR</given-names>
              </name>
              <name>
                <surname>Bonney</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Yount</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Pearce</surname>
                <given-names>BD</given-names>
              </name>
            </person-group>
            <article-title>Weathering the storm; a review of pre-pregnancy stress and risk of spontaneous abortion.</article-title>
            <source>Psychoneuroendocrinology</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>92</volume>
            <fpage>142</fpage>
            <page-range>142-154</page-range>
            <pub-id pub-id-type="pmid">29628283</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Deshmukh</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Way</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>Immunological Basis for Recurrent Fetal Loss and Pregnancy Complications.</article-title>
            <source>Annu Rev Pathol</source>
            <year>2019</year>
            <month>Jan</month>
            <day>24</day>
            <volume>14</volume>
            <fpage>185</fpage>
            <page-range>185-210</page-range>
            <pub-id pub-id-type="pmid">30183507</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <collab>Annual Capri Workshop Group</collab>
            <article-title>Early pregnancy loss: the default outcome for fertilized human oocytes.</article-title>
            <source>J Assist Reprod Genet</source>
            <year>2020</year>
            <month>May</month>
            <volume>37</volume>
            <issue>5</issue>
            <fpage>1057</fpage>
            <page-range>1057-1063</page-range>
            <pub-id pub-id-type="pmid">32193767</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Regan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Braude</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Trembath</surname>
                <given-names>PL</given-names>
              </name>
            </person-group>
            <article-title>Influence of past reproductive performance on risk of spontaneous abortion.</article-title>
            <source>BMJ</source>
            <year>1989</year>
            <month>Aug</month>
            <day>26</day>
            <volume>299</volume>
            <issue>6698</issue>
            <fpage>541</fpage>
            <page-range>541-5</page-range>
            <pub-id pub-id-type="pmid">2507063</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sapra</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Joseph</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Galea</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bates</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Louis</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Ananth</surname>
                <given-names>CV</given-names>
              </name>
            </person-group>
            <article-title>Signs and Symptoms of Early Pregnancy Loss.</article-title>
            <source>Reprod Sci</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>24</volume>
            <issue>4</issue>
            <fpage>502</fpage>
            <page-range>502-513</page-range>
            <pub-id pub-id-type="pmid">27342274</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <collab>Practice Committee of the American Society for Reproductive Medicine</collab>
            <article-title>Evaluation and treatment of recurrent pregnancy loss: a committee opinion.</article-title>
            <source>Fertil Steril</source>
            <year>2012</year>
            <month>Nov</month>
            <volume>98</volume>
            <issue>5</issue>
            <fpage>1103</fpage>
            <page-range>1103-11</page-range>
            <pub-id pub-id-type="pmid">22835448</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Metwally</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ong</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Ledger</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>TC</given-names>
              </name>
            </person-group>
            <article-title>Does high body mass index increase the risk of miscarriage after spontaneous and assisted conception? A meta-analysis of the evidence.</article-title>
            <source>Fertil Steril</source>
            <year>2008</year>
            <month>Sep</month>
            <volume>90</volume>
            <issue>3</issue>
            <fpage>714</fpage>
            <page-range>714-26</page-range>
            <pub-id pub-id-type="pmid">18068166</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maraka</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ospina</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>O'Keeffe</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Espinosa De Ycaza</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Gionfriddo</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Erwin</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Coddington</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Stan</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Murad</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Montori</surname>
                <given-names>VM</given-names>
              </name>
            </person-group>
            <article-title>Subclinical Hypothyroidism in Pregnancy: A Systematic Review and Meta-Analysis.</article-title>
            <source>Thyroid</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>26</volume>
            <issue>4</issue>
            <fpage>580</fpage>
            <page-range>580-90</page-range>
            <pub-id pub-id-type="pmid">26837268</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xiong</surname>
                <given-names>YQ</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zou</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>The risk of maternal parvovirus B19 infection during pregnancy on fetal loss and fetal hydrops: A systematic review and meta-analysis.</article-title>
            <source>J Clin Virol</source>
            <year>2019</year>
            <month>May</month>
            <volume>114</volume>
            <fpage>12</fpage>
            <page-range>12-20</page-range>
            <pub-id pub-id-type="pmid">30897374</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Benson</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Holt</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Gore</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Callegari</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Chipman</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Kessler</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Dalton</surname>
                <given-names>VK</given-names>
              </name>
            </person-group>
            <article-title>Early Pregnancy Loss Management in the Emergency Department vs Outpatient Setting.</article-title>
            <source>JAMA Netw Open</source>
            <year>2023</year>
            <month>Mar</month>
            <day>01</day>
            <volume>6</volume>
            <issue>3</issue>
            <fpage>e232639</fpage>
            <pub-id pub-id-type="pmid">36920395</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Prine</surname>
                <given-names>LW</given-names>
              </name>
              <name>
                <surname>MacNaughton</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Office management of early pregnancy loss.</article-title>
            <source>Am Fam Physician</source>
            <year>2011</year>
            <month>Jul</month>
            <day>01</day>
            <volume>84</volume>
            <issue>1</issue>
            <fpage>75</fpage>
            <page-range>75-82</page-range>
            <pub-id pub-id-type="pmid">21766758</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bourne</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>A missed opportunity for excellence: the NICE guideline on the diagnosis and initial management of ectopic pregnancy and miscarriage.</article-title>
            <source>J Fam Plann Reprod Health Care</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>41</volume>
            <issue>1</issue>
            <fpage>13</fpage>
            <page-range>13-9</page-range>
            <pub-id pub-id-type="pmid">25512352</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Doubilet</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Benson</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Bourne</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Blaivas</surname>
                <given-names>M</given-names>
              </name>
              <collab>Society of Radiologists in Ultrasound Multispecialty Panel on Early First Trimester Diagnosis of Miscarriage and Exclusion of a Viable Intrauterine Pregnancy</collab>
              <name>
                <surname>Barnhart</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Benacerraf</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Filly</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Fox</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Goldstein</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Kendall</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Lyons</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Porter</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Pretorius</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Timor-Tritsch</surname>
                <given-names>IE</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic criteria for nonviable pregnancy early in the first trimester.</article-title>
            <source>N Engl J Med</source>
            <year>2013</year>
            <month>Oct</month>
            <day>10</day>
            <volume>369</volume>
            <issue>15</issue>
            <fpage>1443</fpage>
            <page-range>1443-51</page-range>
            <pub-id pub-id-type="pmid">24106937</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <collab>American College of Obstetricians and Gynecologists' Committee on Practice Bulletins&#x02014;Gynecology</collab>
            <article-title>ACOG Practice Bulletin No. 193: Tubal Ectopic Pregnancy.</article-title>
            <source>Obstet Gynecol</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>131</volume>
            <issue>3</issue>
            <fpage>e91</fpage>
            <page-range>e91-e103</page-range>
            <pub-id pub-id-type="pmid">29470343</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barnhart</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Cary</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Morse</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Takacs</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Senapati</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sammel</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Differences in Serum Human Chorionic Gonadotropin Rise in Early Pregnancy by Race and Value at Presentation.</article-title>
            <source>Obstet Gynecol</source>
            <year>2016</year>
            <month>Sep</month>
            <volume>128</volume>
            <issue>3</issue>
            <fpage>504</fpage>
            <page-range>504-511</page-range>
            <pub-id pub-id-type="pmid">27500326</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <collab>Committee on Practice Bulletins&#x02014;Gynecology</collab>
            <article-title>ACOG Practice Bulletin No. 191: Tubal Ectopic Pregnancy.</article-title>
            <source>Obstet Gynecol</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>131</volume>
            <issue>2</issue>
            <fpage>e65</fpage>
            <page-range>e65-e77</page-range>
            <pub-id pub-id-type="pmid">29232273</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schreiber</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Chavez</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Whittaker</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Ratcliffe</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Easley</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Barg</surname>
                <given-names>FK</given-names>
              </name>
            </person-group>
            <article-title>Treatment Decisions at the Time of Miscarriage Diagnosis.</article-title>
            <source>Obstet Gynecol</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>128</volume>
            <issue>6</issue>
            <fpage>1347</fpage>
            <page-range>1347-1356</page-range>
            <pub-id pub-id-type="pmid">27824749</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schreiber</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Creinin</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Atrio</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sonalkar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ratcliffe</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Barnhart</surname>
                <given-names>KT</given-names>
              </name>
            </person-group>
            <article-title>Mifepristone Pretreatment for the Medical Management of Early Pregnancy Loss.</article-title>
            <source>N Engl J Med</source>
            <year>2018</year>
            <month>Jun</month>
            <day>07</day>
            <volume>378</volume>
            <issue>23</issue>
            <fpage>2161</fpage>
            <page-range>2161-2170</page-range>
            <pub-id pub-id-type="pmid">29874535</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vallera</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>LO</given-names>
              </name>
              <name>
                <surname>Cha</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Hong</surname>
                <given-names>RW</given-names>
              </name>
            </person-group>
            <article-title>Uterotonic Medications: Oxytocin, Methylergonovine, Carboprost, Misoprostol.</article-title>
            <source>Anesthesiol Clin</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>35</volume>
            <issue>2</issue>
            <fpage>207</fpage>
            <page-range>207-219</page-range>
            <pub-id pub-id-type="pmid">28526143</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <collab>Committee on Practice Bulletins-Gynecology, American College of Obstetricians and Gynecologists</collab>
            <article-title>ACOG Practice Bulletin #53. Diagnosis and treatment of gestational trophoblastic disease.</article-title>
            <source>Obstet Gynecol</source>
            <year>2004</year>
            <month>Jun</month>
            <volume>103</volume>
            <issue>6</issue>
            <fpage>1365</fpage>
            <page-range>1365-77</page-range>
            <pub-id pub-id-type="pmid">15172880</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <article-title>Practice Bulletin No. 181: Prevention of Rh D Alloimmunization.</article-title>
            <source>Obstet Gynecol</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>130</volume>
            <issue>2</issue>
            <fpage>e57</fpage>
            <page-range>e57-e70</page-range>
            <pub-id pub-id-type="pmid">28742673</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shorter</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Atrio</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Schreiber</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Management of early pregnancy loss, with a focus on patient centered care.</article-title>
            <source>Semin Perinatol</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>43</volume>
            <issue>2</issue>
            <fpage>84</fpage>
            <page-range>84-94</page-range>
            <pub-id pub-id-type="pmid">30739750</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eschenbach</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Treating spontaneous and induced septic abortions.</article-title>
            <source>Obstet Gynecol</source>
            <year>2015</year>
            <month>May</month>
            <volume>125</volume>
            <issue>5</issue>
            <fpage>1042</fpage>
            <page-range>1042-1048</page-range>
            <pub-id pub-id-type="pmid">25932831</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fouks</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Samueloff</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Levin</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Many</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Amit</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Assessing the effectiveness of empiric antimicrobial regimens in cases of septic/infected abortions.</article-title>
            <source>Am J Emerg Med</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>38</volume>
            <issue>6</issue>
            <fpage>1123</fpage>
            <page-range>1123-1128</page-range>
            <pub-id pub-id-type="pmid">31443937</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pek</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Heil</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Getting With the Times: A Review of Peripartum Infections and Proposed Modernized Treatment Regimens.</article-title>
            <source>Open Forum Infect Dis</source>
            <year>2022</year>
            <month>Sep</month>
            <volume>9</volume>
            <issue>9</issue>
            <fpage>ofac460</fpage>
            <pub-id pub-id-type="pmid">36168554</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Quenby</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gallos</surname>
                <given-names>ID</given-names>
              </name>
              <name>
                <surname>Dhillon-Smith</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Podesek</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Stephenson</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Fisher</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Brosens</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Brewin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ramhorst</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lucas</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>McCoy</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Daher</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Regan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Al-Memar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bourne</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>MacIntyre</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Rai</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Christiansen</surname>
                <given-names>OB</given-names>
              </name>
              <name>
                <surname>Sugiura-Ogasawara</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Odendaal</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Devall</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Bennett</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Petrou</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Coomarasamy</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss.</article-title>
            <source>Lancet</source>
            <year>2021</year>
            <month>May</month>
            <day>01</day>
            <volume>397</volume>
            <issue>10285</issue>
            <fpage>1658</fpage>
            <page-range>1658-1667</page-range>
            <pub-id pub-id-type="pmid">33915094</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schliep</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Mumford</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Radin</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Zarek</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Sjaarda</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Schisterman</surname>
                <given-names>EF</given-names>
              </name>
            </person-group>
            <article-title>Trying to Conceive After an Early Pregnancy Loss: An Assessment on How Long Couples Should Wait.</article-title>
            <source>Obstet Gynecol</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>127</volume>
            <issue>2</issue>
            <fpage>204</fpage>
            <page-range>204-12</page-range>
            <pub-id pub-id-type="pmid">26942344</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sundermann</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Hartmann</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Torstenson</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Velez Edwards</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>Interpregnancy Interval After Pregnancy Loss and Risk of Repeat Miscarriage.</article-title>
            <source>Obstet Gynecol</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>130</volume>
            <issue>6</issue>
            <fpage>1312</fpage>
            <page-range>1312-1318</page-range>
            <pub-id pub-id-type="pmid">29112656</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stirrat</surname>
                <given-names>GM</given-names>
              </name>
            </person-group>
            <article-title>Recurrent miscarriage.</article-title>
            <source>Lancet</source>
            <year>1990</year>
            <month>Sep</month>
            <day>15</day>
            <volume>336</volume>
            <issue>8716</issue>
            <fpage>673</fpage>
            <page-range>673-5</page-range>
            <pub-id pub-id-type="pmid">1975862</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r46">
          <label>46</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Pillarisetty</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Mahdy</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <chapter-title>Recurrent Pregnancy Loss</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>28</day>
            <pub-id pub-id-type="pmid">32119347</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29399.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Birch</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Gulati</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mandalia</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Cervical shock: a complication of incomplete abortion.</article-title>
            <source>BMJ Case Rep</source>
            <year>2017</year>
            <month>Jul</month>
            <day>14</day>
            <volume>2017</volume>
            <pub-id pub-id-type="pmid">28710197</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
